Intracavitary Injection of hUMSCs in Acute Basal Ganglia Hematoma After Stereotactic Aspiration

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT04074408

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04074408
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04074408. Randomized; single masking; primary purpose treatment. Start 2020-05 (anticipated); primary completion 2022-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intracavitary Injection of hUMSCs in Acute Basal Ganglia Hematoma After Stereotactic Aspiration
Condition
Basal Ganglia Hematoma
Intervention (Procedure)
stereotactic surgery
Intervention (Biological)
hUMSCs
Intervention (Biological)
placebo
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine (class: other)
Collaborator
The First Affiliated Hospital, University of Science and Technology of China (class: other)
Collaborator
Zhejiang University (class: other)
Collaborator
First Affiliated Hospital of Fujian Medical University (class: other)
Collaborator
Jinhua Hospital, School of Medicine, Zhejiang University (class: not stated)
Collaborator
Taizhou Hospital (class: other)

Record details

Record id
cardio:ct-nct04074408
Content hash
1547106ae95a16cdf58122734f12e2c3b29891fad23f456a364bab5bd60db46c